Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design

Abstract excerpt

Abstract Current vaccines that provide protection against infectious diseases have primarily relied on attenuated or inactivated pathogens. Virus‐like particles (VLPs), comprised of capsid proteins that can initiate an immune response but do not include the genetic material required for replication, promote immunogenicity and have been developed and approved as vaccines in some cases. In addition, many of these...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacteriophages and microbial interactions
• Share to Immunotherapy and Immune Responses
• Share to Respiratory viral infections research